Coleman, Robert L. https://orcid.org/0000-0001-9343-8754
Fleming, Gini F. https://orcid.org/0000-0003-2845-4023
Brady, Mark F. https://orcid.org/0000-0001-6700-2981
Swisher, Elizabeth M.
Steffensen, Karina D. https://orcid.org/0000-0002-9217-3907
Friedlander, Michael
Okamoto, Aikou
Moore, Kathleen N.
Leath, Charles A. III
Cella, David https://orcid.org/0000-0002-9881-4541
Sun, Zhaowen
Patel, Shilpen
Tang, Zequn
Ratajczak, Christine K.
Aghajanian, Carol https://orcid.org/0000-0003-0851-3225
Bookman, Michael A.
Funding for this research was provided by:
AbbVie Inc
This article is maintained by: Elsevier
Article Title: Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results
Journal Title: European Journal of Cancer
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejca.2025.115587
Content Type: article
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.